[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-334117-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-334117-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","cd147-expression-as-a-clinicopathological-and-prognostic-indicator-in-breast-cancer-a-meta-analysis-and-bioinformatics-analysis","CD147 expression as a clinicopathological and prognostic indicator in breast cancer - a meta-analysis and bioinformatics analysis","","Meta and bioinformatic analyses were conducted to clarify the relationship between CD147 (Basigin) expression and clinicopathological features, prognosis, and survival in breast cancer. Literature from PubMed and CNKI was synthesized with Review Manager 5.2. CD147 expression in tumor tissue exceeded that in normal tissue, and high expression showed negative associations with LM, clinical stage, histological grade, and ER positivity. Bioinformatics further linked CD147 to immune infiltration via TIMER.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/cd147-expression-as-a-clinicopathological-and-prognostic-indicator-in-breast-cancer-a-meta-analysis-and-bioinformatics-analysis/334117/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/cd147-expression-as-a-clinicopathological-and-prognostic-indicator-in-breast-cancer-a-meta-analysis-and-bioinformatics-analysis/334117.png","ImageObject",300,407,{"name":42,"@type":43},"Quinn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-04","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is the purpose of analyzing CD147 in breast cancer?","Question",{"text":63,"@type":64},"To explore whether CD147 expression correlates with clinicopathological characteristics and prognosis in breast cancer, using meta-analysis and bioinformatics.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was the evidence collected and analyzed?",{"text":68,"@type":64},"Relevant breast cancer literature was retrieved from PubMed and CNKI, and the meta-analysis was performed using Review Manager 5.2.",{"name":70,"@type":61,"acceptedAnswer":71},"What did the meta-analysis show about CD147 expression?",{"text":72,"@type":64},"CD147 expression in breast cancer tissue was higher than in normal tissue and was negatively associated with LM, clinical stage, histological grade, and ER-positive expression.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},334117,1790554156,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Shi et al. BMC Cancer (2024) 24:1429  \n[https://doi.org/10.1186/s12885-024-13202-9](https://doi.org/10.1186/s12885-024-13202-9)  \nBMC Cancer  \n SYSTEMATIC REVIEW Open Access  \nCD147 expression as a clinicopathological and prognostic indicator in breast cancer: a meta-analysis and bioinformatics analysis  \nShuai Shi1, Hong-Yan Ma 1, Yin-zhou Sang1, Ying-bo Ju 1, Xing-guang Wang1 and Zhi-Gang Zhang1*  \nAbstract  \nBackground CD147 belongs to the immunoglobulin superfamily, also known as Basigin (BSG), and is a highly glycosylated single transmembrane glycoprotein present in various tissues. Meta and bioinformatic analyses were used to explore the correlation between CD147 expression and the clinicopathological characteristics prognosis of breast cancer.  \nMethod Literature related to breast cancer was retrieved through PubMed and CNKI databases, and a meta-analysis was conducted using Review Manager 5.2 software.  \nResults The meta-analysis revealed that all articles included data on 522 patients with breast cancer and 492 normal tissues. CD147 expression in breast cancer tissue was higher compared to that in normal tissue([8 .92–139. 52]; p \u003C 0.00001 I2 = 80%) and negatively correlated with LM, clinical stage, histological grade, and ER positive expression. Bioinformatic analysis revealed that the expression of CD147 in breast cancer tissue was higher than that in normal tissue, and its high expression was closely related to the clinicopathological characteristics of patients, such as LM, histological grading, and clinical staging. According to the TIMER database, CD147 expression was closely related to immune cell infiltration in breast cancer.  \nConclusion These results indicated that high CD147 expression might be closely linked to the occurrence as well as the development of breast cancer, and can function as a good indicator of prognosis in the future, providing new methods and ideas for the prevention and treatment of breast cancer.  \nKeywords CD147, Breast cancer, Prognostic, Meta analysis, Bioinformatic analysis  \nIntroduction  \nBreast cancer is the leading malignant tumor threatening women’s health [1]. There are approximately 420,000 new cases and 120,000 deaths from breast cancer in Chinese women each year, ranking first among new cases of malignant tumors in women, which poses  \n*Correspondence:  \nZhi-Gang Zhang [zhzhg001518@126.com](zhzhg001518@126.com)  \n1 Department of Pathology, Cangzhou People’s Hospital, 7 Qingchi Avenue, Cangzhou City 061000, China  \nsignificant challenges to women’s life and health [2]. Despite advancements in the publicawareness regarding breast cancer prevention, treatment, and self-examination, the increasing trend of its incidence rate remainsescalating. Some patients often miss the best treatment opportunity because they do not seek medical treatment in a timely manner, leading to the progression of tumor staging and the emergence of related complications, which seriously affects their future survival [3]. Therefore, it is necessary to find novel markers with high sensitivity and specificity to evaluate the progression, prognosis, and survival of breast cancer.  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statut","cbCaihVInjoNFaj1","https://ap.wps.com/l/cbCaihVInjoNFaj1","pdf",3597310,11,"English","# Abstract\n## Background\n## Method\n## Results\n## Conclusion\n# Introduction\n## CD147 gene and biological features\n## CD147 roles in tumor invasion and metastasis","[{\"question\":\"What is the purpose of analyzing CD147 in breast cancer?\",\"answer\":\"To explore whether CD147 expression correlates with clinicopathological characteristics and prognosis in breast cancer, using meta-analysis and bioinformatics.\"},{\"question\":\"How was the evidence collected and analyzed?\",\"answer\":\"Relevant breast cancer literature was retrieved from PubMed and CNKI, and the meta-analysis was performed using Review Manager 5.2.\"},{\"question\":\"What did the meta-analysis show about CD147 expression?\",\"answer\":\"CD147 expression in breast cancer tissue was higher than in normal tissue and was negatively associated with LM, clinical stage, histological grade, and ER-positive expression.\"}]","CD147 expression as a clinicopathological and prognostic indicator in breast cancer - a meta-analysis and bioinformatics analysis | PDF",1790005365,28]